Skip to section navigation
Skip to page content

Global Health and Wellbeing

Research, commentary, and events

Project
COVID-19 and the cost of vaccine nationalism
Without a vaccine, the worldwide economic impact of COVID-19 could be $3.4 trillion a year. But even when a vaccine is available, an unequal allocation of COVID-19 vaccines could cost the global economy up to $1.2 trillion a year in GDP.
28 Oct 2020
Project
How Middle Eastern SMEs are coping with COVID-19
A survey of small and medium-sized enterprises in the Middle East and Turkey, targeted particularly at businesses owned by migrants, women and young people, sought to understand the impact of COVID-19 on their work and what can be done to support them during the pandemic.
06 Jul 2020
Project
Examining violence against healthcare
RAND Europe explored the nature of violence against healthcare, the impact of this violence, and corresponding interventions on a global scale – the first time an evidence review of this scale has been undertaken in this area.
01 Jul 2020
Commentary
How to best enable pharma innovation beyond the COVID-19 crisis
Innovating in response to public health challenges like COVID-19 does not always align well with pharmaceutical industry commercial models or shareholder expectations. More sustainable and scalable ways of incentivising innovation in response to infectious disease threats are needed.
26 May 2020
Project
Economic benefits of malaria control
Investing in malaria vaccination for children in sub-Saharan Africa not only helps in reducing malaria cases and deaths, it could also have long term macroeconomic benefits according to an economic model researchers developed.
09 Jan 2020
Project
Evaluation suggests next steps for Dance4Life
Dance4life, an international youth initiative to raise awareness and promote prevention of HIV/AIDS, developed and piloted a new programme and implementation model. An evaluation of the pilot found many successes but also areas where improvements could be made.
21 Nov 2018
Project
Evaluating the Impact of EU R&D into PRNDs
EU-funded research and development into poverty-related and neglected diseases has had a significant impact on strengthening research capacity in low- and middle-income countries, but its effects on encouraging universal health coverage is less clear.
21 Feb 2018
Commentary
New Partnerships for Improving Global Health Research
Partnerships between public and private organizations have become a powerful mechanism for addressing longer-term and structural challenges faced by developing countries that have a high burden of poverty-related diseases.
22 Sep 2015
Commentary
Probing the Barriers to Conducting Clinical Research in Sub-Saharan Africa
Developing clinical research in sub-Saharan Africa requires a more holistic approach that considers not only individuals and institutions concerned with clinical research but also the wider health and research systems in these countries.
19 Sep 2014
Project
Evaluating the Wellcome Trust's African Institutions Initiative
An evaluation of the Wellcome Trust's African Institutions Initiative (AII) shows several successes as well as recommendations for the future. The AII funds consortia to build sustainable, independent health research capacity at African universities and research organisations, to promote research collaboration and to train individuals for research careers in Africa.
12 Sep 2014

Page 1 of 2
1
2
Next